Inovio Pharmaceuticals, Inc.
What this means
- Net loss in 2025Net loss of $85M for the year (2024: −$107M).
- Revenue downRevenue fell from $218K in 2024 to $65K in 2025 (70% lower).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $65K | $218K |
| Net income (loss) | −$85M | −$107M |
| Total assets | $74.3M | $113M |
| Total liabilities | $50.2M | $44.7M |
| Stockholders’ equity | $24.1M | $68.5M |
| Cash and equivalents | $44.3M | $65.8M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- INOVIO PHARMACEUTICALS, INC.
Formerly: Inovio Biomedical Corp - CIK
- 0001055726
- Tickers
- INO
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Business address
- Plymouth Meeting, Pennsylvania
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 10, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
- Form 8-K · items 2.02, 9.01 · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
- Form 8-K · items 2.02 · filed Nov 5, 2026 · filing
- Form 10-Q · filed Aug 12, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 12, 2026 · filing
- Form 8-K · items 2.02 · filed Jul 29, 2026 · filing
- Form 10-Q · filed May 13, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 13, 2026 · filing
- Form 10-K · filed Mar 12, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 12, 2026 · filing
- Form 10-Q · filed Nov 10, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 10, 2025 · filing
- Form 10-Q · filed Aug 12, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 12, 2025 · filing
- Form 10-Q · filed May 13, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 13, 2025 · filing
- Form 10-K · filed Mar 18, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 18, 2025 · filing
- Form 10-Q · filed Nov 14, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 14, 2024 · filing
- Form 10-Q · filed Aug 8, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 8, 2024 · filing
- Form 8-K · items 5.02, 5.07 · filed May 28, 2024 · filing
- Form 10-Q · filed May 13, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 13, 2024 · filing
- Form 10-K · filed Mar 6, 2024 · filing
- Form 10-Q · filed Nov 9, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 9, 2023 · filing
- Form 8-K · items 3.01 · filed Nov 2, 2023 · filing
- Form 10-Q · filed Aug 9, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 9, 2023 · filing
- Form 8-K · items 2.05 · filed Aug 1, 2023 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed May 18, 2023 · filing
- Form 10-Q · filed May 10, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 10, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 1, 2023 · filing
- Form 10-K · filed Mar 1, 2023 · filing
- Form 8-K · items 2.05, 7.01, 8.01, 9.01 · filed Jan 31, 2023 · filing